{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:13:06Z","timestamp":1785859986984,"version":"3.56.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Chimeric antigen receptor T-cell (CAR-T) therapy has transformed outcomes in hematologic malignancies but is frequently complicated by cardiovascular toxicity, most notably in the setting of cytokine release syndrome. While systemic inflammation, endothelial activation, and myocardial stress have been implicated, the mechanistic links between immune activation and cardiac injury remain incompletely understood. Exosomes and other extracellular vesicles (EVs) have emerged as critical mediators of intercellular communication during immune responses, carrying bioactive cargo including cytokines, microRNAs, proteins, and lipids that can modulate cardiovascular function. In the context of CAR-T therapy, EVs derived from activated T-cells, tumor cells, and injured endothelium may amplify inflammatory signaling, promote endothelial dysfunction, and contribute directly to myocardial injury. Importantly, EVs are detectable in peripheral blood and exhibit dynamic changes in concentration and cargo during CAR-T\u2013associated toxicities, positioning them as promising biomarkers for early detection, risk stratification, and prognostication of cardiac injury. This review synthesizes current evidence on the biogenesis, functional roles, and cardiovascular effects of exosomes and EVs in CAR-T therapy, highlighting their potential as mechanistic mediators and translational biomarkers. We also discuss existing knowledge gaps, technical challenges in EV characterization, and future directions for integrating EV-based diagnostics into cardio-oncology practice.<\/jats:p>","DOI":"10.1097\/crd.0000000000001246","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:00:24Z","timestamp":1776312024000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exosomes and Extracellular Vesicles in CAR-T Cell Therapy: Emerging Mediators and Biomarkers of Cardiac Injury"],"prefix":"10.1097","author":[{"given":"Jatin","family":"Thukral","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyush","family":"Moudgil","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gian Sagar Medical College and Hospital, Ramnagar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninaad","family":"Sindhwani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gian Sagar Medical College and Hospital, Ramnagar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gian Sagar Medical College and Hospital, Ramnagar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Makkar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gian Sagar Medical College and Hospital, Ramnagar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gian Sagar Medical College and Hospital, Ramnagar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya Kaushal","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harbir","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hamilton Medical Center, Dalton, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Thukral","sequence":"additional","affiliation":[{"name":"Department of Occupational Therapy, Pt. Deendayal Upadhyaya National Institute for Persons With Physical Disabilities, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth Pravin","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, New York Medical College\/Landmark Medical Center, Woonsocket, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College and Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College and Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"R1-20260416","doi-asserted-by":"crossref","first-page":"103693","DOI":"10.1016\/j.htct.2024.06.008","article-title":"From the mechanism of action to clinical management: a review of cardiovascular toxicity in adult treated with CAR-T therapy.","volume":"47","author":"Nunes","year":"2025","journal-title":"Hematol Transfus Cell Ther"},{"key":"R2-20260416","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/medicina60050800","article-title":"Racial disparities in cardiovascular and cerebrovascular adverse events in patients with non-Hodgkin lymphoma: a nationwide analysis.","volume":"60","author":"Chandani","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"R3-20260416","doi-asserted-by":"crossref","first-page":"891","DOI":"10.12688\/f1000research.138264.1","article-title":"Racial disparities in major cardiovascular and cerebrovascular adverse events in breast cancer survivors: a nationwide analysis.","volume":"12","author":"Jain","year":"2023","journal-title":"F1000Research"},{"key":"R4-20260416","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13287-024-03783-4","article-title":"CAR-T cell-derived exosomes: a new perspective for cancer therapy.","volume":"15","author":"Sani","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"R5-20260416","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.120.049254","article-title":"Therapeutic and diagnostic translation of extracellular vesicles in cardiovascular diseases: roadmap to the clinic.","volume":"143","author":"Sahoo","year":"2021","journal-title":"Circulation"},{"key":"R6-20260416","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles.","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R7-20260416","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"R8-20260416","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes.","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"R9-20260416","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions.","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"R10-20260416","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles.","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R11-20260416","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.vph.2015.02.008","article-title":"Exosomes and exosomal miRNAs in cardiovascular protection and repair.","volume":"71","author":"Emanueli","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"R12-20260416","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCRESAHA.117.310752","article-title":"Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and epidemiology.","volume":"120","author":"Jansen","year":"2017","journal-title":"Circ Res"},{"key":"R13-20260416","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI87316","article-title":"Extracellular vesicles: masters of intercellular communication and potential clinical interventions.","volume":"126","author":"Pitt","year":"2016","journal-title":"J Clin Invest"},{"key":"R14-20260416","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrrheum.2014.19","article-title":"Emerging role of extracellular vesicles in inflammatory diseases.","volume":"10","author":"Buzas","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R15-20260416","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/imr.13027","article-title":"Secret messengers: extracellular RNA communication in the immune system.","volume":"304","author":"Nation","year":"2021","journal-title":"Immunol Rev"},{"key":"R16-20260416","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases.","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol Ther"},{"key":"R17-20260416","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/cvr\/cvac031","article-title":"Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles.","volume":"119","author":"Davidson","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R18-20260416","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/mmr.2024.13171","article-title":"CAR-T cell therapy: a breakthrough in traditional cancer treatment strategies (Review).","volume":"29","author":"Sun","year":"2024","journal-title":"Mol Med Rep"},{"key":"R19-20260416","doi-asserted-by":"crossref","first-page":"e230622206353","DOI":"10.2174\/1573403X18666220623152350","article-title":"Cardiovascular toxicities with chimeric antigen receptor T-cell therapy.","volume":"19","author":"Gill","year":"2023","journal-title":"Curr Cardiol Rev"},{"key":"R20-20260416","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.3390\/jcm12196124","article-title":"Exploring CAR-T cell therapy side effects: mechanisms and management strategies.","volume":"12","author":"Zhang","year":"2023","journal-title":"J Clin Med"},{"key":"R21-20260416","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2026.01.006","article-title":"Effectiveness and safety of apixaban versus warfarin in atrial fibrillation patients with malignancy: a propensity-matched analysis.","volume":"264","author":"Agrawal","year":"2026","journal-title":"Am J Cardiol"},{"key":"R22-20260416","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.beha.2017.09.002","article-title":"Cytokine release syndrome: who is at risk and how to treat.","volume":"30","author":"Frey","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"R23-20260416","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/bjh.18596","article-title":"Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells.","volume":"201","author":"Galli","year":"2023","journal-title":"Br J Haematol"},{"key":"R24-20260416","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1182\/bloodadvances.2021004716","article-title":"Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy.","volume":"5","author":"Johnsrud","year":"2021","journal-title":"Blood Adv"},{"key":"R25-20260416","doi-asserted-by":"crossref","first-page":"101147","DOI":"10.1016\/j.neo.2025.101147","article-title":"Exosomes in review: a new frontier in CAR-T cell therapies.","volume":"62","author":"Wang","year":"2025","journal-title":"Neoplasia"},{"key":"R26-20260416","doi-asserted-by":"crossref","first-page":"e2309857","DOI":"10.1002\/advs.202309857","article-title":"Hypoxic exosomal circPLEKHM1-mediated crosstalk between tumor cells and macrophages drives lung cancer metastasis.","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"R27-20260416","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1158\/0008-5472.CAN-22-2220","article-title":"Tumor-derived small extracellular vesicles inhibit the efficacy of CAR T cells against solid tumors.","volume":"83","author":"Zhong","year":"2023","journal-title":"Cancer Res"},{"key":"R28-20260416","doi-asserted-by":"crossref","first-page":"1615526","DOI":"10.3389\/fphar.2025.1615526","article-title":"Cytokine release syndrome and CAR T Cell therapy: modulating the intensity of the inflammatory response and resolution within the tumor microenvironment.","volume":"16","author":"Driscoll","year":"2025","journal-title":"Front Pharmacol"},{"key":"R29-20260416","first-page":"10.3791\/68726","article-title":"Enhancing chimeric antigen receptor-extracellular vesicles (CAR-EV) technology: the future of cancer therapy.","volume":"223","author":"Asari","year":"2025","journal-title":"J Vis Exp"},{"key":"R30-20260416","doi-asserted-by":"crossref","first-page":"11063","DOI":"10.1111\/jcmm.17029","article-title":"Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia.","volume":"25","author":"Hong","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R31-20260416","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3390\/pharmaceutics13091525","article-title":"Endothelial-derived extracellular vesicles induce cerebrovascular dysfunction in inflammation.","volume":"13","author":"Roig-Carles","year":"2021","journal-title":"Pharmaceutics"},{"key":"R32-20260416","doi-asserted-by":"crossref","first-page":"e180900","DOI":"10.1172\/JCI180900","article-title":"Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes.","volume":"135","author":"Collado","year":"2025","journal-title":"J Clin Invest"},{"key":"R33-20260416","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/09612033251330099","article-title":"Association between extracellular vesicles (EVs) and thrombosis in antiphospholipid syndrome.","volume":"34","author":"Jacintho-Robison","year":"2025","journal-title":"Lupus"},{"key":"R34-20260416","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1213\/ANE.0000000000006988","article-title":"Endothelium-derived extracellular vesicles expressing intercellular adhesion molecules reflect endothelial permeability and sepsis severity.","volume":"139","author":"Takei","year":"2024","journal-title":"Anesth Analg"},{"key":"R35-20260416","doi-asserted-by":"crossref","first-page":"103369","DOI":"10.1016\/j.ebiom.2021.103369","article-title":"Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.","volume":"67","author":"Balbi","year":"2021","journal-title":"EBioMedicine"},{"key":"R36-20260416","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/biom13101470","article-title":"Circulating small extracellular vesicles reflect the severity of myocardial damage in STEMI patients.","volume":"13","author":"Zar\u00e0","year":"2023","journal-title":"Biomolecules"},{"key":"R37-20260416","doi-asserted-by":"crossref","first-page":"eaax8005","DOI":"10.1126\/scitranslmed.aax8005","article-title":"Endothelial extracellular vesicles contain protective proteins and rescue ischemia-reperfusion injury in a human heart-on-chip.","volume":"12","author":"Yadid","year":"2020","journal-title":"Sci Transl Med"},{"key":"R38-20260416","doi-asserted-by":"crossref","first-page":"106790","DOI":"10.1016\/j.vph.2020.106790","article-title":"Extracellular vesicles and cardiovascular system: biomarkers and cardioprotective effectors.","volume":"135","author":"Femmin\u00f2","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"R39-20260416","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1002\/ctm2.979","article-title":"Cardiac troponin T in extracellular vesicles as a novel biomarker in human cardiovascular disease.","volume":"12","author":"Lennon","year":"2022","journal-title":"Clin Transl Med"},{"key":"R40-20260416","doi-asserted-by":"crossref","first-page":"105715","DOI":"10.1016\/j.phrs.2021.105715","article-title":"Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury.","volume":"170","author":"D\u2019Ascenzo","year":"2021","journal-title":"Pharmacol Res"},{"key":"R41-20260416","doi-asserted-by":"crossref","first-page":"952974","DOI":"10.3389\/fcvm.2022.952974","article-title":"Extracellular vesicles in heart failure - a study in patients with heart failure with preserved ejection fraction or heart failure with reduced ejection fraction characteristics undergoing elective coronary artery bypass grafting.","volume":"9","author":"Matan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R42-20260416","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12265-016-9705-1","article-title":"Circulating extracellular vesicles contain miRNAs and are released as early biomarkers for cardiac injury.","volume":"9","author":"Deddens","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"key":"R43-20260416","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.vph.2016.12.002","article-title":"MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1.","volume":"88","author":"Tang","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"R44-20260416","first-page":"779","article-title":"MicroRNA-146a improves sepsis-induced cardiomyopathy by regulating the TLR-4\/NF-\u03baB signaling pathway.","volume":"18","author":"Xie","year":"2019","journal-title":"Exp Ther Med"},{"key":"R45-20260416","doi-asserted-by":"crossref","first-page":"e001249","DOI":"10.1161\/JAHA.114.001249","article-title":"MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.","volume":"3","author":"Jansen","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R46-20260416","doi-asserted-by":"crossref","first-page":"e009220","DOI":"10.1136\/jitc-2024-009220","article-title":"EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed\/refractory multiple myeloma.","volume":"12","author":"Frenking","year":"2024","journal-title":"J ImmunoTher Cancer"},{"key":"R47-20260416","doi-asserted-by":"crossref","first-page":"e004475","DOI":"10.1136\/jitc-2021-004475","article-title":"The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R\/R LBCL.","volume":"10","author":"Rejeski","year":"2022","journal-title":"J ImmunoTher Cancer"},{"issue":"Suppl 2","key":"R48-20260416","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/anae.16493","article-title":"Cardiotoxicity and peri-operative considerations in immune checkpoint inhibitor and chimeric antigen receptor T-cell therapy: a narrative review.","volume":"80","author":"Malode","year":"2025","journal-title":"Anaesthesia"},{"key":"R49-20260416","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.jacc.2021.08.044","article-title":"Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-Cell therapy.","volume":"78","author":"Goldman","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R50-20260416","first-page":"91","article-title":"Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignancies.","volume":"10","author":"Daryanani","year":"2024","journal-title":"Cardiooncology"},{"key":"R51-20260416","doi-asserted-by":"crossref","first-page":"830773","DOI":"10.3389\/fimmu.2022.830773","article-title":"Monitoring of circulating CAR T cells: validation of a flow cytometric assay, cellular kinetics, and phenotype analysis following tisagenlecleucel.","volume":"13","author":"Peinelt","year":"2022","journal-title":"Front Immunol"},{"key":"R52-20260416","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12967-024-06035-4","article-title":"Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells.","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"key":"R53-20260416","doi-asserted-by":"crossref","first-page":"15330338221132927","DOI":"10.1177\/15330338221132927","article-title":"Adverse cardiac effects of CAR T-cell therapy: characteristics, surveillance, management, and future research directions.","volume":"21","author":"Dalal","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"R54-20260416","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s11864-025-01363-z","article-title":"Immunotherapy-associated cardiotoxicity: a comprehensive review of checkpoint inhibitors, monoclonal, cellular, and cytokine-based treatments.","volume":"26","author":"Keramida","year":"2025","journal-title":"Curr Treat Options Oncol"},{"key":"R55-20260416","doi-asserted-by":"crossref","first-page":"e12283","DOI":"10.1002\/jev2.12283","article-title":"Plant-derived extracellular vesicles: recent advancements and current challenges on their use for biomedical applications.","volume":"11","author":"Lian","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"R56-20260416","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/bloodadvances.2024014860","article-title":"CD19.CAR T-cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy.","volume":"9","author":"Lanuti","year":"2025","journal-title":"Blood Adv"},{"key":"R57-20260416","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00216-022-04362-3","article-title":"Advancement and obstacles in microfluidics-based isolation of extracellular vesicles.","volume":"415","author":"Havers","year":"2023","journal-title":"Anal Bioanal Chem"},{"key":"R58-20260416","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12951-023-01917-z","article-title":"Integrating automated liquid handling in the separation workflow of extracellular vesicles enhances specificity and reproducibility.","volume":"21","author":"Van Dorpe","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"R59-20260416","doi-asserted-by":"crossref","first-page":"19","DOI":"10.20517\/jca.2025.30","article-title":"Extracellular vesicles in cardiac regeneration and aging: mechanisms and translation.","volume":"5","author":"Porada","year":"2025","journal-title":"J Cardiovasc Aging"},{"key":"R60-20260416","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.3390\/ijms20246223","article-title":"Optimizing manufacturing protocols of chimeric antigen receptor T cells for improved anticancer immunotherapy.","volume":"20","author":"Stock","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R61-20260416","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jmedgenet-2018-105439","article-title":"Exosomes derived from exhausted CD8+ T cells impaired the anticancer function of normal CD8+ T Cells.","volume":"56","author":"Wang","year":"2019","journal-title":"J Med Genet"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:18:01Z","timestamp":1785856681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001246","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}